A clinical trial has found that low-dose interleukin-2 is both safe and effective for use on people with motor neuron disease ...

A clinical trial has found that low-dose interleukin-2 is safe and may significantly extend survival in people with motor ...

Their input cables, called dendrites, seem to run their own computations, and these alter the way neurons—and their associated networks—function ... while it learned a new motor skill. Depending on ...